Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Reservoir Neuroscience, Inc

Website

Advertisement

Advertisement

6460 Hollis St Ste A
Emeryville, CA 94608
https://www.reservoirneuro.com

Reservoir Neuroscience, Inc is a cutting-edge neuroscience lab located in Emeryville, CA.

With their headquarters situated at 6460 Hollis St, Suite A, Reservoir Neuroscience is at the forefront of groundbreaking research in the field.

Generated from the website

Also at this address

We are Getting Fit LLC

Johnson, Patrice

Ayar Labs

Fight day

Boxing With Us

yelp logo
16 reviews
Own this business?
Claim it
See a problem?

You might also like

Santen Inc

Santen is a wholly owned subsidiary of Santen Pharmaceutical. Located in Northern California s Napa Valley, the United States office is comprised of health care professionals with its senior management team totaling more than 20 years of industry experience, knowledge and expertise based exclusively in the ophthalmic field. In early 2004, Santen entered into a partnership agreement with VISTAKON Pharmaceuticals, granting VISTAKON the exclusive U.S. distribution rights to the Santen ophthalmic products QUIXIN 0.5%, BETIMOL 0.25% and 0.5%, and ALAMAST 0.1%, as well as its newest product IQUIX 1.5%, which gained FDA approval in March 2004. Santen is also actively pursuing technological alliances with a number of pharmaceutical companies and research institutes and has investments in an intraocular lens company. Santen opened its doors in the San Francisco Bay Area in 1993.

Kyverna Therapeutics, Inc

Kyverna Therapeutics is a cell therapy company based in Emeryville, CA, specializing in the development of innovative treatments for autoimmune and inflammatory diseases. Their cutting-edge therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to target and eliminate autoreactive immune cells responsible for these conditions. With a focus on B cell-driven autoimmune diseases, Kyverna's pipeline includes next-generation chimeric antigen receptor T-cell (CAR-T) therapies in both autologous and allogeneic formats. By leveraging their expertise in cell engineering, Kyverna aims to revolutionize the field of cell therapy and provide effective solutions for patients suffering from autoimmune and inflammatory disorders.Generated from the website
Zogenix, Inc
Real estate managers, Drugs and drug proprietaries

Zogenix, Inc

Founded in 2006, Zogenix Inc. is a privately held, specialty pharmaceutical company. It develops and commercializes differentiated central nervous system (CNS) and pain therapeutics that can address significant unmet medical needs or overcome limitations of existing products. Zogenix Inc has received approval from the Food and Drug Administration (FDA) for SUMAVEL DosePro (sumatriptan injection) needle-free delivery system, which is a drug-device combination that enables needle-free delivery of subcutaneous sumatriptan for the treatment of acute migraine and cluster headache. The company s other product, ZX002, is a novel controlled release formulation of hydrocodone for the treatment of chronic pain. Zogenix Inc. is supported by several investors, including Abingworth Management Ltd., Clarus Ventures, Domain Associates, Scale Venture Partners, Thomas, McNerney & Partner and others.
United States›California›Emeryville›Reservoir Neuroscience, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell